Volume 49, Issue 1, Pages (January 2013)

Slides:



Advertisements
Similar presentations
Volume 43, Issue 1, Pages (July 2011)
Advertisements

Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states by Thu-Hang Pham, Christopher.
Volume 17, Issue 12, Pages (December 2016)
Volume 42, Issue 1, Pages (January 2015)
Volume 38, Issue 4, Pages (May 2010)
Volume 16, Issue 12, Pages (September 2016)
Volume 39, Issue 4, Pages (August 2010)
Volume 56, Issue 1, Pages (October 2014)
Volume 11, Issue 2, Pages (August 2012)
Volume 44, Issue 3, Pages (November 2011)
Volume 54, Issue 1, Pages (April 2014)
Volume 53, Issue 6, Pages (March 2014)
N6-Methyladenosines Modulate A-to-I RNA Editing
Nucleosome-Driven Transcription Factor Binding and Gene Regulation
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 17, Issue 4, Pages (October 2015)
Volume 60, Issue 4, Pages (November 2015)
Volume 17, Issue 5, Pages (October 2016)
Volume 16, Issue 12, Pages (September 2016)
Volume 33, Issue 4, Pages (February 2009)
Mapping Global Histone Acetylation Patterns to Gene Expression
The Stat3/GR Interaction Code: Predictive Value of Direct/Indirect DNA Recruitment for Transcription Outcome  David Langlais, Catherine Couture, Aurélio.
Volume 43, Issue 5, Pages (September 2011)
Volume 25, Issue 2, Pages (February 2017)
Volume 38, Issue 4, Pages (May 2010)
Volume 48, Issue 5, Pages (December 2012)
Volume 47, Issue 2, Pages e5 (August 2017)
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites to Alter the Breast Cancer Cell Transcriptome  Hector L. Franco, Anusha Nagari, W. Lee Kraus 
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Volume 55, Issue 3, Pages (August 2014)
Volume 54, Issue 4, Pages (May 2014)
Volume 62, Issue 1, Pages (April 2016)
Volume 22, Issue 3, Pages (March 2012)
Volume 46, Issue 1, Pages (April 2012)
Volume 42, Issue 6, Pages (June 2011)
Volume 44, Issue 3, Pages (November 2011)
Volume 15, Issue 4, Pages (April 2012)
Volume 10, Issue 10, Pages (October 2017)
Volume 14, Issue 5, Pages (February 2016)
Volume 29, Issue 5, Pages (March 2008)
Volume 35, Issue 2, Pages (August 2011)
Xudong Wu, Jens Vilstrup Johansen, Kristian Helin  Molecular Cell 
Irina M. Bochkis, Dariusz Przybylski, Jenny Chen, Aviv Regev 
Polycomb Protein Ezh1 Promotes RNA Polymerase II Elongation
Volume 55, Issue 5, Pages (September 2014)
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 5, Pages (November 2007)
Volume 64, Issue 5, Pages (December 2016)
Volume 55, Issue 5, Pages (September 2014)
Volume 42, Issue 6, Pages (June 2011)
Volume 63, Issue 3, Pages (August 2016)
Volume 35, Issue 1, Pages (July 2009)
Volume 48, Issue 1, Pages (October 2012)
DNA Looping Facilitates Targeting of a Chromatin Remodeling Enzyme
Volume 7, Issue 2, Pages (August 2010)
Volume 39, Issue 3, Pages (September 2013)
Volume 133, Issue 5, Pages (May 2008)
Anne Pfeiffer, Hui Shi, James M. Tepperman, Yu Zhang, Peter H. Quail 
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Volume 56, Issue 6, Pages (December 2014)
Volume 32, Issue 5, Pages (May 2010)
Volume 22, Issue 2, Pages (April 2006)
Volume 66, Issue 3, Pages e6 (May 2017)
Volume 24, Issue 1, Pages 1-10 (January 2014)
Volume 17, Issue 3, Pages (October 2016)
Volume 64, Issue 5, Pages (December 2016)
Volume 52, Issue 1, Pages (October 2013)
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor α-Bound Enhancers  Julia B. Carleton, Kristofer.
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Presentation transcript:

Volume 49, Issue 1, Pages 158-171 (January 2013) Insights into Negative Regulation by the Glucocorticoid Receptor from Genome-wide Profiling of Inflammatory Cistromes  N. Henriette Uhlenhaut, Grant D. Barish, Ruth T. Yu, Michael Downes, Malith Karunasiri, Christopher Liddle, Petra Schwalie, Norbert Hübner, Ronald M. Evans  Molecular Cell  Volume 49, Issue 1, Pages 158-171 (January 2013) DOI: 10.1016/j.molcel.2012.10.013 Copyright © 2013 Elsevier Inc. Terms and Conditions

Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 GR, AP-1, and NF-κB Cistromes Intersect (A) Area-proportional Venn diagram of GR cistromes in unstimulated (orange) and stimulated (red) macrophages. (B) Motif analysis of the GR cistrome in macrophages treated with Dex only. (C) Area-proportional Venn diagram showing the overlap between GR, c-Jun, and p65 ChIP-seq peaks in macrophages treated with LPS and Dex. Genomic regions with significant peak scores were merged and given a 100 bp margin for co-occurrence. (D) Globally enriched motifs within the GR, c-Jun, and p65 cistromes in response to LPS. Tables show the top 5–6 statistically overrepresented binding sites. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Genomic Localization of GR, AP-1, and NF-κB Binding in Macrophages (A–D) ChIP-sequencing tracks of regulatory regions of GR target genes in macrophages treated with LPS and/or Dex, normalized to 10 million reads. (A) IL6 locus with overlapping GR, p65, and c-Jun occupancy. (B) IL6 proximal promoter displaying GR binding only in the presence of c-Jun and p65. (C) Ccl2 locus with overlapping GR, p65, and c-Jun binding. GR binding is LPS independent. (D) Irf1 locus with GR binding induced by LPS, but independent of p65 and c-Jun (arrow). Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Correlating Gene Expression and Recruitment in Response to LPS and Dex (A) Heat map cluster showing the numbers and overlap of microarray probe sets that were upregulated (red) or downregulated (light green) at least 1.5-fold in macrophages treated with LPS and/or Dex. (B) Graph showing ChIP peaks assigned to differentially expressed genes and correlating gene expression with occupancy by GR, c-Jun, and p65. Percentages and numbers reflect fractions of GR ChIP peaks. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Activation versus Repression by GR (A) Luciferase assays using reporters containing ChIP peak sequences that were linked to activated genes. Black bars represent percent induction in response to Dex. Bottom legend lists occupancy of GR/c-Jun/p65 as determined by ChIP-seq in primary macrophages. (B) De novo motif discovery on ChIP peak sequences that were assigned to genes activated by Dex. (C) Luciferase assays using reporters containing ChIP peak sequences that were assigned to repressed genes. Black bars represent percent repression in response to Dex. Bottom legend lists occupancy of GR/c-Jun/p65 as determined by ChIP-seq in primary macrophages. (D) De novo motif discovery on ChIP peak sequences that were assigned to genes repressed by Dex. (E) Luciferase assays using reporters that were repressed by GR in (C) and that now contain a point mutation in the GRE motif. (F) Luciferase assays performed in CV-1 cells (devoid of endogenous GR) using GR point mutants that abolish DNA binding (C421G and C441G). Error bars represent SEM. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 GR Recruits GRIP1 to Activated and Repressed Genes (A) Area-proportional Venn diagram of GRIP1 cistromes in LPS-stimulated (light blue) and Dex-treated (cyan) macrophages. (B) Area-proportional Venn diagram showing the overlap between GRIP1 and GR ChIP-seq peaks in macrophages treated with LPS and Dex. Arrows and numbers on bottom right represent ChIP peaks associated with GR-repressed versus -activated genes. (C) Globally enriched motifs found in the GRIP1 cistrome in response to LPS + Dex. (D) ChIP-sequencing tracks of regulatory regions of GR target genes in macrophages treated with LPS ± Dex, normalized to 10 million reads. Ligand-dependent GRIP1 recruitment can be observed at activated (Tlr2, Per1) and repressed (IL6, Ccl2) enhancers. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 GR Repression Includes GRIP-1 Corepressor Function and Opposition of IRF3 Activity (A) siRNA knockdown of GR and GRIP-1 in RAW264.7 macrophages treated with LPS and/or Dex. Reduction of both GR and GRIP-1 expression levels impairs repression of LPS-induced genes Il1a, Il6, Nos2, Mmp13, and Tnfsf10 by Dex, but only GR knockdown affects the positively regulated gene Gilz. Brackets above bars show p values for differential expression in LPS versus LPS + Dex treated cells (∗ p < 0.01; n.s., not significant). (B) siRNA knockdown experiments in RAW264.7 cells. Knockdown of IRF3 affects expression of LPS-induced and Dex-repressed GR target genes, but not Dex-activated genes such as Gilz. Error bars represent SD. (C) Representative examples of IRF3 ChIP-seq tracks. IRF3 binding co-occurs with the presence of GR and GRIP1 at repressed genes such as Il1a, but not at activated genes like Gilz. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Repression by GR Involves Selective HDAC Recruitment and Histone Deacetylation (A) ChIP-seq experiments in primary macrophages show a reduction in acetylated histone H3K9 marks at sites repressed in response to Dex in both unstimulated and TLR4-activated conditions. (B) At repressed enhancers such as Nos2, Il6, etc., Dex treatment leads to increased recruitment of HDAC2 and/or HDAC3, as determined by ChIP experiments. (C) Conversely, HAT activity is increased in response to Dex at activated enhancers (i.e., Dusp1), as determined by ChIP experiments using α-CBP and α-p300 antibodies, but not at repressed loci. Error bars represent SD. Molecular Cell 2013 49, 158-171DOI: (10.1016/j.molcel.2012.10.013) Copyright © 2013 Elsevier Inc. Terms and Conditions